A novel superdisintegrating agent made from physically modified chitosan with silicon dioxide

Drug Development and Industrial Pharmacy

Volumn 34, Issue 4, 2008, Pages 373-383

  El Barghouthi, Musa ^a   Eftaiha, Ala'a ^a   Rashid, Iyad ^b   Al Remawi, Mayyas ^b   Badwan, Adnan ^b  

^a HASHEMITE UNIVERSITY   (Jordan)

^b JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

Author keywords

Chitosan silica; Coprecipitation; Superdisintegrant

Indexed keywords

AEROSIL; CHITOSAN; CROSCARMELLOSE SODIUM; DISINTEGRATING AGENT; EXCIPIENT; HYDROXYPROPYLCELLULOSE; METFORMIN; POVIDONE; SILICON DIOXIDE; STARCH GLYCOLATE SODIUM; TALC;

ARTICLE; DRUG FORMULATION; GELATION; HYDROPHILICITY; INFRARED SPECTROSCOPY; POWDER DIFFRACTION; PRECIPITATION; TABLET COMPRESSION; TENSILE STRENGTH; WATER TRANSPORT; WETTABILITY;

CHEMISTRY, PHARMACEUTICAL; CHITOSAN; EXCIPIENTS; HARDNESS; HYDROPHOBICITY; PRECIPITATION; SILICON DIOXIDE; SOLUBILITY; TABLETS;

EID: 42049086327     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701657792     Document Type: Article

References (44)

1. Akbuga, J. (1995). A biopolymer: Chitosan. Int. J. Pharm. Adv., 1, 1-18.
2. Augsburger, L. L., Brzecko, A. W., Shah, U., & Hahm, H. A. (2000). Characterization and functionality of super disintegrants. In J. Swarbrick & J. C. Boylan (Eds.), Encyclopedia of pharmaceutical technology (pp. 269-291). New York: Marcel Dekker.
3. Badwan, A., & Al-Remawi, M. (2007). Chitosan-silicon dioxide coprecipitate as an excipient in solid dosage forms. Eur. Pat. Appl., 23. Jordan: The Jordanian Pharmaceutical Manufacturing Co.
4. Borzacchielo, A., Ambrosias, L., Netter, P., Nicholais, L., Balard, A., & Sam, P. (2001). Chitosan-based hydrogels: Synthesis and characterization. J. Mater. Sci.: Mater. Med., 12, 861-864.
5. Bussemer, T., Peppas, N. A., & Bodmeier, R. (2003). Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur. J. Pharm. Biopharm., 56, 261-270.
6. Caramella, C., Ferrari, M., Ronchi, A., Gazzaniga, U., Conte, A. L., & LaManna, A. (1989). Relationships between water uptake and disintegration force in tablets of differing solubility. Congres. Int. Technol. Pharm., 3, 256-265.
7. Cerai, P., Guerra, G. D., & Tricoli, M. (1996). Polyelectric complexes obtained by radical polymerization in the presence of chitosan macromolecular chemistry and physics. Macromol. Chem., 197, 3367.
8. Cerehiara, T., Luppi, B., Bigueei, F., & Zeeehi, V. (2003). Chitosan and salts as nasal sustained delivery systems for peptidic drugs. J. Pharm. Pharmacol., 55, 1623-1627.
9. Chen, C. R., Lin, Y. H., Cho, S. L., Yen, S. Y., & Wu, H. L. (1997). Investigation of the dissolution difference between acidic and neutral media of acetaminophen tablets containing a super disintegrant and a soluble excipient. Chem. Pharm. Bull., 45, 509-512.
10. Dos Santos, D. S., Bassi, A., Rodrigues, J. J., Miosoguti, L., Oliveira, O. N., & Mendonac, C. R. (2003). Light-induced storage in layer-by-layer films of chitosan and an azo dye. Biomacromolecules, 4(6), 1502-1505.
11. Freyer, K. M. P., & Brink, D. (2006). Evaluation of powder and tableting properties of chitosan. AAPS PharmSciTech., 7(3), Article 75.
12. Gbenga, A., & Oludele, A. I. (2003). Effects of starches on the mechanical properties of paracetamol tablet formulations. II. Sorghum and plantain starches as disintegrants. Acta. Pharm., 53, 313-320.
13. Giunchedi, P., Juliano, C., Gavini, E., Cossu, M., & Sorrenti, M. (2002). Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur. J. Pharm. Biopharm., 53, 233-239.
14. Ilkka, J., & Paronen, P. (1993). Prediction of the compression behavior of powder mixtures by the Heckel equation. Int. J. Pharm., 94, 181-187.
15. Illum, L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm. Res., 15, 1326-1331.
16. Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A. N., & Davis, S. S. (2001). Chitosan as a novel nasal delivery system for vaccines. Adv. Drug. Deli. Rev., 51(81), 1-3.
17. Khan, K. A., & Rhodes, C. T. (1975). Water-sorption properties of tablet disintegrants. Pharm. Sci., 64(3), 447-451.
18. Knapczyk, J. (1993). Excipient ability of chitosan for direct tableting. Int. J. Pharm., 89, 1-7.
19. Kothari, S. H., Kumar, V., & Banker, G. S. (2002). Comparative evaluations of powder and mechanical properties of low crystallinity celluloses, microcrystalline celluloses, and powdered celluloses. Int. J. Pharm., 232(1-2), 69-80.
20. Lachman, L., Liberman, L., & Schwartz, J. (1989). Pharmaceutical dosage forms, tablets (Vol. 2; pp. 173-177). New York: Marcel Dekker.
21. Leuenberger, H., & Kuentz, M. (2000). A new theoretical approach to tablet strength of a binary mixture consisting of a well and a poorly compactable substance. Eur. J. Pharm. Biopharm., 49, 151-159.
22. Lonso, M. J., & Sanchez, A. (2003). The potential of chitosan in ocular drug delivery. J. Pharm. Pharmacol., 55, 1451-1463.
23. Marina, L., & Ali, R. R. S. (2004). The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J. Pharm. Sci., 93(11), 2746-2753.
24. Maryyann, F., & Pierre, D. (2003). Research universities and local economic development: Lessons from the history of Johns Hopkins University. Industry Innovation, 10(1), 5-24.
25. Mukesh, C, G., Rajesh, K. P., Bansari, K. B., & Aarohi, R. S. (2007). Preparation and assessment of novel coprocessed superdisintegrant consisting of crospovidone and sodium starch glycolate. AAPS PharmSciTech., 8(1), Article 9.
26. Muzzarelli, R. A. A., Baldassare, V., Conti, F., Gazzanelli, G., Vasi, V., Ferrara, P., & Biangini, G. (1988). The biological activity of chitosan: Ultrastructural study. Biomaterial, 8, 247-252.
27. Nunthanid, J., Puttipipatkhachorn, S., Yamamoto, K., & Peck, G. E. (2001). Physical properties and molecular behavior of chitosan films. Drug Dev. Ind. Pharm., 27, 143-157.
28. Pankaj, R. R., & Lawrence, H. B. (1999). Chitosan processing: Influence of process parameters during acidic and alkaline hydrolysis and effect of the processing sequence on the resultant chitosan's properties. Carbohydr. Res., 321, 235-245.
29. Paronen, P., & Iilla, J. (1996). Porosity-pressure functions. In, G. Alderborn & C. Nystrom (Eds.), Pharmaceutical powder compaction technology (pp. 55-75). New York: Marcel Dekker.
30. Rawas-Qalaji, M. M., Simons, F. E. R., & Simons, K. J. (2006). Fast-disintegrating Sublingual Tablets: Effect of Epinephrine load on tablet characteristics AAPS PharmSciTech., 7(2) Article 41.
31. Ritthidej, G. C., Chomoto, P., & Pammangusa, S. (1994). Chitin and chitosan as disintegrants in paracetamol tablets. Drug Dev. Ind. Pharm., 20(13), 2109-2114.
32. Robert, R., & Vojko, K. (2005). Evaluation of the moisture sorption behaviour of several excipients by BET, GAB and microcalorimetric approaches. Chem. Pharm. Bull., 53(6), 662-665.
33. Sakhr, A., Bose, M., & Menon, A. (1993). Comparative effectiveness of super disintegrants on the characteristics of directly compressed triamterene hydrochlorothiazide tablets. Pharm. Ind., 55, 953-957.
34. Shangraw, R. F., Mitrevej, A., & Shah, M. (1980). A new era of tablet disintegrants. Pharm. Technol., 4(10), 49-57.
35. Skaugrud, O. (1991). Chitosan-new biopolymer for cosmetics and drugs. Drug Cosmetic Ind., 148, 24-29.
36. Soares, L. L., Ortega, G. G., Petrovick, P. R., & Schmidt, P. C. (2005). Optimization of tablets containing a high dose of spray-dried plant extract: A technical note. AAPS PharmSciTech., 06(03), E367-E371.
37. Tatsuya, I., Baku, M., Shuji, S., Naoki, U., Makiko, F., Mitsuo, M., & Yoshiteru, W. (2001). Preparation of rapidly disintegrating tablets using new type of MCC (PH-M-series) and L-HPC by direct compression method. Chem. Pharm. Bull., 49(2), 134-139.
38. Taylor, M. K., Ginsburg, J., Hickey, A., & Gheyas, F. (2000). Composite method to quantify powder flow as a screening method in early tablet or capsule formulation development. AAPS PharmSciTech., 1(3), Article 18.
39. Van Veen, B., & Bolhuis, G. K. (2005). Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline cellulose. Eur. J. Pharm. Biopharm., 59(1), 133-138.
40. Vansant, E. F., Van Der Veport, P., & Vrancken, K. C. (1995). Characterization and chemical modification of silica surface (chap. 8.3). Amsterdam, New York: Elsevier Science Publishing.
41. Weast, R.C. (Ed.). (1974-1975). Handbook of chemistry and physics (55th ed.; p. E-46). Boca Raton, FL: CRC Press.
42. Zhao, N., & Augsburger, L. L. (2005). The influence of swelling capacity of super disintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech., 6(01), 120-126.
43. Zhao, N., & Augsburger, L. L. (2006). The influence of granulation on super disintegrant performance. Pharm. Dev. Technol., 11(1), 47-53.
44. United States pharmacopeia and national formulary (USP30-NF25: Vol. 1, p. 644). (2007). Rockville, MD: US Pharmacopoeia Convention.